Bond.az White LogoBond.az Black Logo

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

Matthew King
ByMatthew King- Senior Editor
|
0

USA Rare Earth, Inc. (NASDAQ: USAR) has announced plans to invest approximately €175 million in France through 2030 to expand its metal, alloy and magnet manufacturing operations.

The investment builds on existing French initiatives, including a rare earth metal and alloy facility at Lacq operated by subsidiary Less Common Metals, and a strategic investment in Carester SAS alongside InfraVia Capital Partners. The expansion could create over 300 jobs.

The company said the investment would be made with French government incentives, including the C3IV program, with potential additional support through debt guarantees and a possible direct equity investment. Plans align with agreements with the U.S. Department of Commerce.

CEO Barbara Humpton spoke at the Choose France summit in Paris, confirming magnet manufacturing in France as a key objective.

USA Rare Earth operates across the rare earth value chain through its ownership of Less Common Metals, magnet manufacturing development in Stillwater, Oklahoma, the Pela Ema mine in Brazil, and the Round Top deposit in Texas.

Recently, the company reported Q1 2026 earnings beating expectations with EPS of -$0.12 vs. -$0.14 expected. It also secured up to $19.3 million in federal funding from the U.S. Department of Energy.

More News
2026-06-01 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
2026-06-01 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
2026-06-01 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
2026-06-01 11:33
|
363

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

0
2026-06-01 08:31
|
890

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
2026-06-01 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
2026-06-01 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
2026-06-01 07:30
|
762

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
2026-06-01 07:04
|
680

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
2026-06-01 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
2026-06-01 07:00
|
543

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
2026-06-01 06:34
|
620

Redcentric Appoints Tim Sykes as CFO

Redcentric appoints Tim Sykes as CFO. With 30+ years of experience, Sykes will drive growth in the MSP business.

0
...